By Professor Gail Matthews

Journal articles

Jin F; Prestage G; Matthews G; Zablotska I; Rawstorne PR; Kippax SC; Kaldor JM; Grulich AE, 2010, 'Prevalence, incidence and risk factors for hepatitis C in homosexual men: data from two cohorts of HIV-negative and HIV-positive men in Sydney, Australia', Sexually Transmitted Infections, 86, pp. 25 - 28, http://dx.doi.org/10.1136/sti.2009.038182

Haber P; Hellard M; Matthews GV; Grebely J; Petoumenos K; Yeung B; Marks P; Van Beek I; Kaldor J; Dore GJ, 2009, 'TREATMENT OF RECENT HEPATITIS C VIRUS INFECTION IN A PREDOMINANTLY INJECTION DRUG USER COHORT: THE ATAHC STUDY', DRUG AND ALCOHOL REVIEW, 28, pp. A27 - A27, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270916300083&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Gandhi M; Fox NS; Russo-Stieglitz K; Hanley ME; Matthews G; Rebarber A, 2009, 'Effect of increased body mass index on first-trimester ultrasound examination for aneuploidy risk assessment', Obstetrics and Gynecology, 114, pp. 856 - 859, http://dx.doi.org/10.1097/AOG.0b013e3181b6bfdc

Matthews GV; Hellard M; Dore GJ, 2009, 'Reply', Clinical Infectious Diseases, 49, pp. 319, http://dx.doi.org/10.1086/600059

Matthews G; Hellard M; Haber P; Yeung B; Marks PB; Baker D; McCaughan G; Sasadeusz J; White PA; Rawlinson WD; Lloyd AR; Kaldor JM; Dore GJ; Dolan K, 2009, 'Characteristics and treatment outcomes among HIV-infected individuals in the Australian Trial in acute hepatitis C', Clinical Infectious Diseases, 48, pp. 650 - 658, http://dx.doi.org/10.1086/596770

Matthews G; Seaberg E; Dore GJ; Bowden S; Lewin S; Sasadeusz J; Marks P; Goodman Z; Philp F; Tang Y; Locarnini S; Thio C, 2009, 'Combination HBV therapy is linked to greater HBV DNA suppression in a cohort of lamivudine-experienced HIV/HBV coinfected individuals', AIDS, 23, pp. 1707 - 1715, http://dx.doi.org/10.1097/QAD.0b013e32832b43f2

van de Laar T; Pybus O; Bruisten S; Brown D; Nelson M; Bhagani S; Vogel M; Baumgarten A; Chaix M; Fisher M; Gotz H; Matthews G; Neifer S; White PA; Rawlinson W; Pol S; Rockstroh J; Coutinho RA; Dore GJ; Dusheiko GM; Danta M, 2009, 'Evidence of a Large, International Network of HCV Transmission in HIV-Positive Men Who Have Sex With Men', Gastroenterology, 136, pp. 1609 - 1617, http://dx.doi.org/10.1053/j.gastro.2009.02.006

Matthews G; Dore GJ, 2009, 'HIV and hepatitis C co-infection', Asian Biomedicine, 3, pp. 29 - 37

Crane M; Oliver B; Matthews G; Avihingsanon A; Ubolyam S; Markovska V; Chang JJ; Dore GJ; Price P; Visvanathan K; French MA; Ruxrungtham K; Lewin S, 2009, 'Immunopathogenesis of hepatic flare in HIV/hepatitis B virus (HBV)-coinfected individuals after the initiation of HBV-active antiretroviral therapy', Journal of Infectious Diseases, 199, pp. 974 - 981

Chang JH; Sirivichayakul S; Avihingsanon A; Thompson A; Revill P; Iser D; Slavin J; Buranapraditkun S; Marks P; Matthews G; Cooper DA; Kent SJ; Cameron P; Sasadeusz J; Desmond PV; Locarnini S; Dore GJ; Ruxrungtham K; Lewin S, 2009, 'Impaired Quality of the Hepatitis B Virus (HBV)-Specific T-Cell Response in Human Immunodeficiency Virus Type 1-HBV Coinfection', Journal of Virology, 83, pp. 7649 - 7658

Matthews G; Hellard M; Dore GJ, 2009, 'Initial Presentation of Acute Hepatitis C Virus (HCV) Infection among HIV-Negative and HIV-Positive Individuals-Experience from 2 Large German Networks on the Study of Acute HCV Infection Reply', Clinical Infectious Diseases, 49, pp. 319 - 319, http://dx.doi.org/10.1086/600059

Haber P; Hellard M; Matthews GV; Grebely J; Petoumenos K; Yeung B; Marks P; van Beek I; McCaughan G; White PA; Ffrench R; Rawlinson W; Lloyd A; Kaldor J; Dore GJ, 2009, 'Treatment of recent hepatitis C virus infection in a predominantly injection drug user cohort: the ATAHC Study', The Canadian Journal of Addiction, 1, pp. 33 - 33, http://dx.doi.org/10.1097/02024458-200912000-00072

Lewin S; Ribiero R; Avihingsanon A; Bowden S; Matthews G; Marks P; Locarnini S; Ruxrungtham K; Perelson AS; Dore GJ, 2009, 'Viral dynamics of hepatitis B virus DNA in human immunodeficiency virus-1-hepatitis B virus coinfected individuals: Similar effectiveness of lamivudine, tenofovir, or combination therapy', Hepatology, 49, pp. 1113 - 1121

Crane M; Matthews G; Lewin SR, 2008, 'Hepatitis virus immune restoration disease of the liver', Current Opinion in HIV and AIDS, 3, pp. 446 - 452, http://dx.doi.org/10.1097/COH.0b013e3282fdc953

Matthews G; Avihingsanon A; Lewin S; Amin J; Rerknimitr R; Petcharapirat P; Marks PB; Sasadeusz J; Cooper DA; Bowden S; Locarnini S; Ruxrungtham K; Dore GJ, 2008, 'A randomized trial of combination hepatitis B therapy in HIV/HBV coinfected antiretroviral naive individuals in Thailand', Hepatology, 48, pp. 1062 - 1069

Preiss S; Littlejohn M; Angus PA; Thompson A; Desmond PV; Lewin S; Sasadeusz J; Matthews G; Dore GJ; Shaw T; Sozzi V; Yuen L; Lau GT; Ayres A; Thio C; Avihingsanon A; Ruxrungtham K; Locarnini S; Revill P, 2008, 'Defective hepatitis B virus DNA is not associated with disease status but is reduced by polymerase mutations associated with drug resistance', Hepatology, 48, pp. 741 - 749

Matthews G; Dore GJ, 2008, 'HIV and hepatitis C coinfection', Journal of Gastroenterology and Hepatology, 23, pp. 1000 - 1008

Stark D; van Hal S; Matthews G; Harkness JL; Marriott D, 2008, 'Invasive amebiasis in men who have sex with men, Australia', Emerging Infectious Diseases, 14, pp. 1141 - 1143

Sasadeusz J; Audsley J; Mijch AM; Baden R; Caro J; Hunter H; Matthews G; McMahon A; Olender S; Siliciano R; Susan A; Lewin S; Thio C, 2008, 'The anti-HIV activity of entecavir: a multicentre evaluation of lamivudine-experienced and lamivudine-naive patients', AIDS, 22, pp. 947 - 955

Matthews G; Grebely J; Dore GJ, 2008, 'The role of re-infection in determining rates of spontaneous clearance after hepatitis C exposure', Journal of Hepatology, 49, pp. 305 - 307, http://dx.doi.org/10.1016/j.jhep.2008.06.005

Matthews G, 2007, 'The management of HIV and hepatitis B coinfection', Current Opinion in Infectious Diseases, 20, pp. 16 - 21, http://dx.doi.org/10.1097/QCO.0b013e328012c5aa

Matthews GV; Seaberg E; Dore GJ; Lewin SR; Bowden S; Sasadeuz J; Marks P; Hoy J; Locarnini S; Thio CL, 2007, 'Combination of HBV-active antiretroviral therapy influences hbv virological suppression in an international cohort of 120 HIVHBV coinfected individuals', JOURNAL OF HEPATOLOGY, 46, pp. S194 - S194, http://dx.doi.org/10.1016/S0168-8278(07)62108-4

Matthews G; Hellard M; Kaldor JM; Lloyd AR; Dore GJ, 2007, 'Further evidence of HCV sexual transmission among HIV-positive men who have sex with men: response to Danta et al', AIDS, 21, pp. 2112 - 2113, http://dx.doi.org/10.1097/qad.0b013e3282ef3873

van Hal S; Muthiah K; Matthews G; Harkness JL; Stark D; Cooper DA; Marriott D, 2007, 'Declining incidence of intestinal microsporidiosis and reduction in AIDS-related mortality following introduction of HAART in Sydney, Australia', Transactions of the Royal Society of Tropical Medicine and Hygiene, 101, pp. 1096 - 1100

Revill P; Littlejohn M; Ayres A; Yuen L; Colledge D; Bartholomeusz A; Sasaduesz J; Lewin S; Dore GJ; Matthews G; Thio C; Locarnini S, 2007, 'Identification of a novel hepatitis B virus precore/core deletion mutant in HIV-1/hepatitis B virus co-infected individuals.', AIDS, 21, pp. 1701 - 1710

Matthews G; Cooper DA; Dore GJ, 2007, 'Improvements in parameters of end-stage liver disease in patients with HIV/HBV-related cirrhosis treated with tenofovir', Antiviral Therapy, 12, pp. 119 - 122

Matthews G; Dore GJ, 2007, 'Response to Schmutz et al., `Combination of tenofovir and lamivudine versus tenofovir after lamivudine failure for therapv of hepatitis B in HIV-coinfection`', AIDS, 21, pp. 777 - 778

Dore GJ; Hellard M; Matthews G; Haber PS; Shaw D; Yeung B; Petoumenos K; Van Beek IA; Mccaughan GW; Pan Y; Ffrench R; Rowlinson W; Lloyd AR; Kaldor JM, 2007, 'Treatment of recently acquired hepatitis C infection in injecting drug users: Preliminary results from the Australian trial in acute hepatitis C (ATAHC)', Hepatology, 46, pp. 358A - 358A

Matthews G; Bartholomeusz A; Locarnini S; Ayres A; Sasaduesz J; Seaberg E; Cooper DA; Lewin S; Dore GJ; Thio C, 2006, 'Characteristics of drug resistant HBV in an international collaborative study of HIV-HBV-infected individuals on extended lamivudine therapy', AIDS, 20, pp. 863 - 870

Menon-Johansson AS; Winston A; Matthews G; Portsmouth S; Daniels D, 2005, 'The first point prevalence study of genital Chlamydia trachomatis infection in young male inmates in the UK', International Journal of STD and AIDS, 16, pp. 799 - 801, http://dx.doi.org/10.1258/095646205774988145

Nelson M; Matthews G; Brook MG; Main J; BHIVA Coinfection Guideline Committee ; British HIV Association , 2005, 'BHIVA guidelines on HIV and chronic hepatitis: coinfection with HIV and hepatitis C virus infection (2005).', HIV Med, 6 Suppl 2, pp. 96 - 106, http://dx.doi.org/10.1111/j.1468-1293.2005.00300.x

Matthews G; Kronborg I; Dore GJ, 2005, 'Treatment for hepatitis C virus infection among current injection drug users in Australia', Clinical Infectious Diseases, 40, pp. S325 - S329

Matthews G; Dore G, 2003, 'Response to Soriano et al., 'Treatment of chronic hepatitis C virus infection: We must target the virus or liver fibrosis?' [3]', AIDS, 17, pp. 2675 - 2676

Bell C; Matthews GV; Nelson MR, 2003, 'Non-nucleoside reverse transcriptase inhibitors - An overview', International Journal of STD and AIDS, 14, pp. 71 - 77, http://dx.doi.org/10.1258/095646203321156827

Nelson M; Portsmouth S; Stebbing J; Atkins M; Barr A; Matthews G; Pillay D; Fisher M; Bower M; Gazzard B, 2003, 'An open-label study of tenofovir in HIV-1 and Hepatitis B virus co-infected individuals', AIDS, 17, http://dx.doi.org/10.1097/00002030-200301030-00002

Nelson MR; Matthews G; Brook MG; Main J; British HIV Association , 2003, 'BHIVA guidelines: coinfection with HIV and chronic hepatitis C virus.', HIV Med, 4 Suppl 1, pp. 52 - 62, http://dx.doi.org/10.1046/j.1468-1293.4.s1.2.x

Matthews G; Dore C, 2003, 'Response to Soriano et al., `Treatment of chronic hepatitis C virusinfection: we must target the virus or liver fibrosis?`', AIDS, 17, pp. I - II

Matthews G; Dore GJ, 2003, 'Treatment of chronic hepatitis c virus infection: we must target the virus or liver fibrosis (letter)?', AIDS, 17, pp. 2675 - 2676

Dean GL; Edwards SG; Ives NJ; Matthews G; Fox EF; Navaratne L; Fisher M; Taylor GP; Miller R; Taylor CB; De Ruiter A; Pozniak AL, 2002, 'Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy', AIDS, 16, pp. 75 - 83, http://dx.doi.org/10.1097/00002030-200201040-00010

Matthews GV; Sabin CA; Mandalia S; Lampe F; Phillips AN; Nelson MR; Bower M; Johnson MA; Gazzard BG, 2002, 'Virological suppression at 6 months is related to choice of initial regimen in antiretroviral-naive patients: A cohort study', AIDS, 16, pp. 53 - 61, http://dx.doi.org/10.1097/00002030-200201040-00008

Matthews GV; Pillay D; Cane P; Ratcliffe D; Gazzard B; Nelson M, 2001, 'Failure of combination therapy with lamivudine and famciclovir following lamivudine monotherapy for hepatitis B virus infection in patients coinfected with human immunodeficiency virus-1', Clinical Infectious Diseases, 33, pp. 2049 - 2054, http://dx.doi.org/10.1086/322655

Matthews GV; Nelson MR, 2001, 'The management of chronic hepatitis B infection', International Journal of STD and AIDS, 12, pp. 353 - 357, http://dx.doi.org/10.1258/0956462011923273

Matthews G; Worrall S; Daniels D, 2001, 'Provision of sexual health services in young offender institutions: Is there gender inequality? [2]', International Journal of STD and AIDS, 12, pp. 130 - 131

Powles T; Matthews G; Bower M, 2000, 'AIDS related systemic non-Hodgkin's lymphoma', Sexually Transmitted Infections, 76, pp. 335 - 341, http://dx.doi.org/10.1136/sti.76.5.335

Matthews GV; Bower M; Mandalia S; Powles T; Nelson MR; Gazzard BG, 2000, 'Changes in acquired immunodeficiency syndrome-related lymphoma since the introduction of highly active antiretroviral therapy', Blood, 96, pp. 2730 - 2734, http://dx.doi.org/10.1182/blood.v96.8.2730

Matthews GV; Bower M; Mandalia S; Powles T; Nelson MR; Gazzard BG, 2000, 'Changes in acquired immunodeficiency syndrome–related lymphoma since the introduction of highly active antiretroviral therapy', Blood, 96, pp. 2730 - 2734, http://dx.doi.org/10.1182/blood.v96.8.2730.h8002730_2730_2734

Matthews GV; Moyle GJ; Mandalia S; Bower M; Nelson M; Gazzard BG, 2000, 'Absence of association between individual thymidine analogues or nonnucleoside analogues and lipid abnormalities in HIV-1-infected persons on initial therapy', Journal of Acquired Immune Deficiency Syndromes, 24, pp. 310 - 315, http://dx.doi.org/10.1097/00126334-200008010-00002

Nelson MR; Matthews GV, 2000, 'Newer treatment strategies in the management of HIV/AIDS', CME Bulletin Sexually Transmitted Infections and HIV, 4, pp. 3 - 5

Matthews G; Bower M; Mandalia S; Powles T; Nelson M; Gazzard B, 2000, '012 AIDS‐related lymphoma in the era of HAART', HIV Medicine, 1, pp. 169 - 169, http://dx.doi.org/10.1046/j.1468-1293.2000.00024-23.x

Dean G; Edwards S; Navaratne L; Matthews G; Fox E; Wood C; Fisher M; Churchill D; Taylor G; De Ruiter A; Taylor C; Pozniak A, 2000, '014 Does TB treatment alter virological and immunological response to HAART?', HIV Medicine, 1, pp. 170 - 170, http://dx.doi.org/10.1046/j.1468-1293.2000.00024-27.x

Back to profile page